White House announces Trump-negotiated Medicaid drug prices

The White House says every Medicaid program will receive Trump-negotiated prescription-drug prices, potentially affecting federal and state spending, manufacturers, and beneficiaries. Prices, legal authority, implementation mechanics, participation requirements, and fiscal effects remain unspecified, making follow-up essential.